• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . Effect of SARS-CoV-2 proteins on vascular permeability

tetano

Editor, Senior Moderator
Elife


. 2021 Oct 25;10:e69314.
doi: 10.7554/eLife.69314.
Effect of SARS-CoV-2 proteins on vascular permeability


Rossana Rauti[SUP] #[/SUP][SUP] 1 [/SUP], Meishar Shahoha[SUP] #[/SUP][SUP] 2 3 [/SUP], Yael Leichtmann-Bardoogo[SUP] #[/SUP][SUP] 1 [/SUP], Rami Nasser[SUP] 4 [/SUP], Eyal Paz[SUP] 2 3 [/SUP], Rina Tamir[SUP] 1 [/SUP], Victoria Miller[SUP] 1 [/SUP], Tal Babich[SUP] 1 2 [/SUP], Kfir Shaked[SUP] 1 2 [/SUP], Avner Ehrlich[SUP] 5 [/SUP], Konstantinos Ioannidis[SUP] 5 [/SUP], Yaakov Nahmias[SUP] 5 [/SUP], Roded Sharan[SUP] 4 [/SUP], Uri Ashery[SUP] 2 3 6 [/SUP], Ben Meir Maoz[SUP] 1 3 6 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome (SARS)-CoV-2 infection leads to severe disease associated with cytokine storm, vascular dysfunction, coagulation, and progressive lung damage. It affects several vital organs, seemingly through a pathological effect on endothelial cells. The SARS-CoV-2 genome encodes 29 proteins, whose contribution to the disease manifestations, and especially endothelial complications, is unknown. We cloned and expressed 26 of these proteins in human cells and characterized the endothelial response to overexpression of each, individually. Whereas most proteins induced significant changes in endothelial permeability, nsp2, nsp5_c145a (catalytic dead mutant of nsp5), and nsp7 also reduced CD31, and increased von Willebrand factor expression and IL-6, suggesting endothelial dysfunction. Using propagation-based analysis of a protein-protein interaction (PPI) network, we predicted the endothelial proteins affected by the viral proteins that potentially mediate these effects. We further applied our PPI model to identify the role of each SARS-CoV-2 protein in other tissues affected by coronavirus disease (COVID-19). While validating the PPI network model, we found that the tight junction (TJ) proteins cadherin-5, ZO-1, and β-catenin are affected by nsp2, nsp5_c145a, and nsp7 consistent with the model prediction. Overall, this work identifies the SARS-CoV-2 proteins that might be most detrimental in terms of endothelial dysfunction, thereby shedding light on vascular aspects of COVID-19.

Keywords: SARS-COV-2; endothelium; human; infectious disease; microbiology; protein interactions; vasculature.
 
Back
Top Bottom